Integrated Dermatology Partners With Kenneth A. Rosen, M.D. Dermatology in Miami

BOCA RATON, Fla.–(BUSINESS WIRE)–#AndrewQueen–Integrated Dermatology, one of the nation’s largest providers of dermatology services, has expanded its South Florida network by partnering with Kenneth A. Rosen, M.D. Dermatology in Miami. The practice, which includes offices in Kendall and Miami Lakes, offers patients general dermatological care and cosmetic procedures. Dr. Rosen is an experienced, board-certified dermatologist … [Read more…]

Dxcover Launches Infrared Platform: Ground-Breaking Technology for Faster Sample Analysis

Dxcover® Infrared Platform enables high-speed, low-cost, and sensitive early detection of multiple cancers DUBLIN–(BUSINESS WIRE)–Dxcover Limited, a clinical stage diagnostics company developing spectroscopic liquid biopsy technology for early detection of multiple cancers, today announced the launch of the Dxcover® platform, a ground-breaking platform that transforms Attenuated Total Reflectance Fourier Transform Infrared (ATR-FTIR) spectroscopy to enable … [Read more…]

Global Pulmonary Sarcoidosis Market Report to 2032 – Insight, Epidemiology and Forecasts – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Pulmonary Sarcoidosis – Market Insight, Epidemiology and Market Forecast -2032” report has been added to ResearchAndMarkets.com’s offering. This report delivers an in-depth understanding of the Pulmonary Sarcoidosis, historical and forecasted epidemiology as well as the Pulmonary Sarcoidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. … [Read more…]

AOP Health Presents Final Results From Its CONTINUATION-PV Study – up to 7.5 Years Treatment With BESREMi® (Ropeginterferon alfa-2b) of Polycythaemia Vera Patients – at EHA 2022 Annual Meeting

VIENNA–(BUSINESS WIRE)–#MPN–AOP Health announced the final results on Ropeginterferon alfa-2b in patients with Polycythaemia Vera (PV) from its CONTINUATION-PV study in an oral presentation at the prestigious EHA (European Hematology Association) 2022 Annual Meeting by Professor Heinz Gisslinger, Medical University of Vienna, Austria 1. Link to abstract Ropeginterferon alfa-2b is a long-acting, mono-pegylated proline interferon … [Read more…]

Biostatistics for the Non-Statistician – 6 Hour Virtual Seminar – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “6-Hour Virtual Seminar on Biostatistics for the Non-Statistician” webinar has been added to ResearchAndMarkets.com’s offering. The use of statistics in clinical trials ensures a valid and robust study that minimizes bias in assessing the efficacy of new drug treatments or medical devices. Participants in this 6-hour virtual seminar will learn the fundamentals of … [Read more…]

GE Healthcare Introduces Wireless Patient Monitoring Solution to Help Clinicians Detect Early Patient Deterioration

Continuous monitoring using wearable sensors in general hospital wards may help detect patient deterioration earlier than traditional spot check methods and assist clinicians in improving patient outcomes1. Wireless monitoring allows earlier patient mobilization, a key indicator for recovery, particularly post-surgery2. This innovative technology was developed at GE Healthcare’s global center of excellence for monitoring solutions … [Read more…]

Kinarus Therapeutics’ KIN001 Shows Strong Antiviral Activity Against SARS-CoV-2 and Variants of Concern

Researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg and Kinarus showed antiviral efficacy of KIN001 against SARS-CoV-2 and its variants of concern in vitro Interim data in Q3 for KINETIC, Phase 2 trial of KIN001 in hospitalized COVID-19 patients KINFAST Phase 2 trial of KIN001 in ambulatory COVID-19 patients to start this summer BASEL, Switzerland–(BUSINESS WIRE)–Kinarus Therapeutics Holding AG … [Read more…]

All Seas Capital Invests in French Medical Centre Group SoMeD

LONDON–(BUSINESS WIRE)–All Seas Capital Fund I (“All Seas Capital”), a pan-European private capital fund that provides flexible long-term financing solutions to leading mid cap companies, announces a growth investment in SoMeD Santé (“SoMeD” or the “Company”), a private medical centre group in France. SoMeD provides a multidisciplinary service, including GP, radiography and dental services, from … [Read more…]

Valneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15

Pfizer will invest €90.5 million in Valneva Planned Phase 3 study confirmed to initiate in Q3 2022 SAINT-HERBLAIN, France & NEW YORK–(BUSINESS WIRE)–Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. (NYSE: PFE) today announced that they have entered into an Equity Subscription Agreement and have updated the terms of … [Read more…]

Deenova´s France Remarkable and Continued Success Extends to French overseas departments: winning Mayotte, GHPSO and I.N.I. Awards

MILAN–(BUSINESS WIRE)–Deenova today disclosed that it expanded its market dominance in France with another net new UniHA competitive award for its D3 ACCED mechatronic solution at Centre Hospitalier de Mayotte in French overseas departments. Additionally, Deenova announced a new competitive tender win at GHPSO Creil & Senlis also for its market leading D3 ACCED mechatronic … [Read more…]